UPDATE : Thursday, December 5, 2019
상단여백
‘Lynparza raises value of precision medicine as anticancer treatment’
AstraZeneca’s Lynparza (ingredient: olaparib), the first PARP (poly ADP rib...
by Kim Yun-mi  |  2019-12-05 16:05
라인
Roche Diagnostics stresses ‘integrated personalized diabetes management’
Roche Diagnostics emphasized the importance of “integrated personalized dia...
by Park Gi-taek  |  2019-12-05 13:01
라인
‘Obesity treatment will drastically change next few years’
An Irish expert on obesity and diabetes said Wednesday that prospects for t...
by Lee Han-soo  |  2019-12-04 18:20
라인
'Insulin is safe, natural replacement therapy for diabetic patients'
In Korea, 20.9 percent of diabetic patients, who have a hemoglobin A1c (HbA...
by Lee Han-soo  |  2019-12-04 17:07
라인
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im  |  2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
Hanmi Pharmaceutical said that it has licensed in FLX475, the world’s first...
by Lee Han-soo  |  2019-12-04 16:16
라인
ISU Abxis starts trial of Gaucher disease treatment in Australia
ISU Abxis said that it has started phase 1 clinical trial of Abcertin, an e...
by Lee Han-soo  |  2019-12-04 16:16
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
Samyang Biopharm USA said Tuesday it has signed a deal to adopt a new immun...
by Jeong Sae-im  |  2019-12-03 15:37
라인
Ildong signs co-promotion contract with GSK Consumer Healthcare
Ildong pharmaceutical said that it will co-promote GSK Consumer Healthcare’...
by Lee Han-soo  |  2019-12-03 15:18
라인
Global diabetes group opens 5-day show in Busan
The International Diabetes Federation (IDF) 2019 conference kicked off for ...
by Lee Han-soo  |  2019-12-03 11:04
라인
LG Chem licenses in US firm’s diagnostic platform tech
LG Chem said that it has licensed in a molecular diagnostic platform techno...
by Lee Han-soo  |  2019-12-02 13:42
라인
Syntekabio views industry’s crisis as opportunity
Syntekabio said that it aims to become the world's first publicly-trade...
by Jeong Sae-im  |  2019-11-29 17:54
라인
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
S. Biomedics said that the Ministry of Food and Drug Safety has approved a ...
by Lee Han-soo  |  2019-11-29 15:42
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
Daewoong Pharmaceutical said its new drug Fexuprazan will challenge the pot...
by Jeong Sae-im  |  2019-11-29 15:23
라인
Hanmi's Chinese partner to start trials for anticancer treatment
Hanmi Pharmaceutical said its Chinese partner Innovent Biologics has begun ...
by Lee Han-soo  |  2019-11-28 17:38
라인
GI Innovation licenses out immunotherapy drug candidate to Chinese firm
GI Innovation said that it has licensed out GI-101, a bispecific fusion pro...
by Lee Han-soo  |  2019-11-28 16:26
라인
Takeda's ovarian cancer drug Zejula to get insurance benefit
The government said it would grant insurance benefit to Takeda's ovaria...
by Lee Han-soo  |  2019-11-28 15:36
라인
ST Pharm submits IND application for colorectal cancer treatment in US
ST Pharm said that it has submitted an investigational new drug application...
by Lee Han-soo  |  2019-11-28 14:52
라인
New Parkinson’s drug Ongentys lands on Korea
SK Chemicals said Thursday it has won local marketing license for Ongentys ...
by Jeong Sae-im  |  2019-11-28 14:52
라인
Experts ascribe excessive diabetes hospitalization to lack of early treatment
Local diabetes experts on Wednesday stressed the need to treat diabetes at ...
by Lee Han-soo  |  2019-11-28 11:26
여백
여백
여백
Back to Top